Cosmetic Regulations Guide: FDA, EU, MoCRA & Global Compliance
Regulatory compliance is non-negotiable in the cosmetic industry. Selling unsafe or improperly labeled products can result in recalls, fines, and lawsuits. This guide covers the essential regulations every formulator and brand owner needs to understand, from FDA requirements to the latest MoCRA updates and international standards.
FDA Cosmetic Regulations (US)
What the FDA requires for cosmetic products sold in the United States.
MoCRA — Modernization of Cosmetics Regulation Act
The biggest change to cosmetic regulation in decades. What it means for your business.
EU Cosmetic Regulations
EU Cosmetics Regulation 1223/2009, CPNP registration, and banned substances.
Claims Substantiation
How to support the claims on your product labels with proper testing.
Safety Documentation and SDS
Safety Data Sheets, ingredient documentation, and product safety files.
VOC and Environmental Regulations
Volatile organic compound limits and environmental compliance.
Frequently Asked Questions
Does the FDA approve cosmetics?
No. The FDA does NOT approve cosmetic products before they go to market (unlike drugs). However, the FDA can take action against products that are adulterated (unsafe) or misbranded (improperly labeled). MoCRA now requires facility registration and product listing.
What is MoCRA?
The Modernization of Cosmetics Regulation Act of 2022 is the most significant update to US cosmetic regulation since 1938. It requires facility registration, product listing, adverse event reporting, safety substantiation, and gives the FDA recall authority.
What's the difference between a cosmetic and a drug?
A cosmetic is a product intended to cleanse or beautify. A drug is intended to treat or prevent disease or affect the body's structure/function. If your product makes drug-like claims (e.g., 'treats acne', 'repairs DNA'), it's regulated as a drug and needs FDA approval.
Do I need to test my products on animals?
No. Animal testing for cosmetics is banned in the EU, India, and several other countries. In the US, it's not required by the FDA. Most companies use in vitro testing, clinical panels, and computer modeling instead.